Rodgers Richard J has filed 31 insider transactions across 3 companies since January 2023.
Most recent transaction: a option exercise of 3800 shares of NOVAVAX INC ($NVAX) on October 29, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct. 29, 2025 | NOVAVAX INC | $NVAX | Rodgers Richard J | Director | M | Restricted Stock Units | 3800 | $0.00 | 0.0000 | 168,195,000 | 100.00% | 0.00% |
| Oct. 29, 2025 | NOVAVAX INC | $NVAX | Rodgers Richard J | Director | M | Common Stock | 3800 | $0.00 | 28,490.0000 | 168,195,000 | 15.39% | 0.00% |
| June 20, 2025 | NOVAVAX INC | $NVAX | Rodgers Richard J | Director | A | Stock Option (Right to Buy) | 28326 | $6.42 | 28,326.0000 | 152,190,000 | 9999.99% | 0.02% |
| June 20, 2025 | NOVAVAX INC | $NVAX | Rodgers Richard J | Director | A | Restricted Stock Units | 18884 | $0.00 | 18,884.0000 | 152,190,000 | 9999.99% | 0.01% |
| June 18, 2025 | ARDELYX, INC. | $ARDX | Rodgers Richard J | Director | A | Common Stock | 21468 | $0.00 | 371,992.0000 | 238,356,222 | 6.12% | 0.01% |
| June 18, 2025 | ARDELYX, INC. | $ARDX | Rodgers Richard J | Director | A | Common Stock | 41551 | $0.00 | 413,543.0000 | 238,356,222 | 11.17% | 0.02% |
| June 18, 2025 | ARDELYX, INC. | $ARDX | Rodgers Richard J | Director | A | Stock Option (Right to Buy) | 54059 | $0.00 | 54,059.0000 | 238,356,222 | 9999.99% | 0.02% |
| June 12, 2025 | NOVAVAX INC | $NVAX | Rodgers Richard J | Not found | M | Common Stock | 10420 | $0.00 | 24,690.0000 | 152,190,000 | 73.02% | 0.01% |
| June 12, 2025 | NOVAVAX INC | $NVAX | Rodgers Richard J | Not found | M | Restricted Stock Units | 10420 | $0.00 | 0.0000 | 152,190,000 | 100.00% | 0.01% |
| April 30, 2025 | Opus Genetics, Inc. | $IRD | Rodgers Richard J | Not found | A | Stock Option (Right to Buy) | 79592 | $0.00 | 79,592.0000 | 26,715,526 | 9999.99% | 0.30% |
| April 30, 2025 | Opus Genetics, Inc. | $IRD | Rodgers Richard J | Not found | A | Common Stock | 79504 | $0.00 | 318,655.0000 | 26,715,526 | 33.24% | 0.30% |
| Jan. 16, 2025 | ARDELYX, INC. | $ARDX | Rodgers Richard J | Director | M | Stock Option (Right to Buy) | 100000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Jan. 16, 2025 | ARDELYX, INC. | $ARDX | Rodgers Richard J | Director | M | Common Stock | 100000 | $0.55 | 350,524.0000 | 0 | 39.92% | 0.00% |
| Oct. 29, 2024 | NOVAVAX INC | $NVAX | Rodgers Richard J | Not found | M | Common Stock | 3800 | $0.00 | 14,270.0000 | 160,049,000 | 36.29% | 0.00% |
| Oct. 29, 2024 | NOVAVAX INC | $NVAX | Rodgers Richard J | Not found | M | Restricted Stock Units | 3800 | $0.00 | 3,800.0000 | 160,049,000 | 50.00% | 0.00% |
| June 14, 2024 | ARDELYX, INC. | $ARDX | Rodgers Richard J | Director | A | Stock Option (Right to Buy) | 40243 | $0.00 | 40,243.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | ARDELYX, INC. | $ARDX | Rodgers Richard J | Director | A | Common Stock | 12204 | $0.00 | 250,524.0000 | 0 | 5.12% | 0.00% |
| June 12, 2024 | NOVAVAX INC | $NVAX | Rodgers Richard J | Not found | M | Common Stock | 6670 | $0.00 | 10,470.0000 | 100,768,000 | 175.53% | 0.01% |
| June 12, 2024 | NOVAVAX INC | $NVAX | Rodgers Richard J | Not found | A | Stock Option (Right to Buy) | 15630 | $15.86 | 15,630.0000 | 100,768,000 | 9999.99% | 0.02% |
| June 12, 2024 | NOVAVAX INC | $NVAX | Rodgers Richard J | Not found | A | Restricted Stock Units | 10420 | $0.00 | 10,420.0000 | 100,768,000 | 9999.99% | 0.01% |
| June 12, 2024 | NOVAVAX INC | $NVAX | Rodgers Richard J | Not found | M | Restricted Stock Units | 6670 | $0.00 | 0.0000 | 100,768,000 | 100.00% | 0.01% |
| June 11, 2024 | Opus Genetics, Inc. | $IRD | Rodgers Richard J | Not found | A | Stock Option (Right to Buy) | 35181 | $0.00 | 35,181.0000 | 21,589,821 | 9999.99% | 0.16% |
| June 11, 2024 | Opus Genetics, Inc. | $IRD | Rodgers Richard J | Not found | A | Common Stock | 41143 | $0.00 | 239,151.0000 | 21,589,821 | 20.78% | 0.19% |
| Jan. 1, 2024 | Opus Genetics, Inc. | $IRD | Rodgers Richard J | Not found | A | Common Stock | 24762 | $0.00 | 198,008.0000 | 21,589,821 | 14.29% | 0.11% |
| Nov. 1, 2023 | Opus Genetics, Inc. | $IRD | Rodgers Richard J | Not found | A | Common Stock | 35000 | $0.00 | 173,246.0000 | 0 | 25.32% | 0.00% |
| Oct. 29, 2023 | NOVAVAX INC | $NVAX | Rodgers Richard J | Director | M | Common Stock | 3800 | $0.00 | 3,800.0000 | 78,183,000 | 9999.99% | 0.00% |
| Oct. 29, 2023 | NOVAVAX INC | $NVAX | Rodgers Richard J | Director | M | Restricted Stock Units | 3800 | $0.00 | 7,600.0000 | 78,183,000 | 33.33% | 0.00% |
| June 12, 2023 | NOVAVAX INC | $NVAX | Rodgers Richard J | Director | A | Stock Option (Right to Buy) | 7710 | $0.00 | 7,710.0000 | 78,183,000 | 9999.99% | 0.01% |
| June 12, 2023 | NOVAVAX INC | $NVAX | Rodgers Richard J | Director | A | Restricted Stock Units | 6670 | $0.00 | 6,670.0000 | 78,183,000 | 9999.99% | 0.01% |
| April 19, 2023 | Opus Genetics, Inc. | $IRD | Rodgers Richard J | Interim CEO and President | A | Common Stock | 50000 | $0.00 | 138,246.0000 | 0 | 56.66% | 0.00% |
| Jan. 11, 2023 | Opus Genetics, Inc. | $IRD | Rodgers Richard J | Not found | A | Common Stock | 20822 | $0.00 | 88,246.0000 | 0 | 30.88% | 0.00% |